Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors

BACKGROUND: The modified Glasgow prognostic score (mGPS), a clinical tool that incorporates albumin and C‐reactive protein, has proven useful in the prognostication of multiple cancers. Several immune checkpoint inhibitors (ICIs) have been approved for the treatment of metastatic urothelial cell car...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Brown, Jacqueline T., Liu, Yuan, Shabto, Julie M., Martini, Dylan J., Ravindranathan, Deepak, Hitron, Emilie Elise, Russler, Greta Anne, Caulfield, Sarah, Yantorni, Lauren Beth, Joshi, Shreyas S., Kissick, Haydn, Ogan, Kenneth, Harris, Wayne B., Carthon, Bradley C., Kucuk, Omer, Master, Viraj A., Bilen, Mehmet Asim
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2021
Matèries:
Genitourinary Cancer
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8100543/
https://ncbi.nlm.nih.gov/pubmed/33634507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13727
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars